Table 3.
Metabolite | Methoda | BGc | oGMc | pWMc | |||
---|---|---|---|---|---|---|---|
Nb | CRLB | N | CRLB | N | CRLB | ||
NAA | SVS-LCM | 32 | 8% ± 2% | 59 | 5% ± 1% | 59 | 5% ± 1% |
wbMRSI | 59 | 4% ± 1% | 59 | 4% ± 1% | 59 | 3% ± 1% | |
Hybrid | 59 | 3% ± 1% | 59 | 2% ± 0% | 59 | 2% ± 0% | |
tCho | SVS-LCM | 32 | 9% ± 3% | 59 | 9% ± 1% | 59 | 7% ± 1% |
wbMRSI | 59 | 6% ± 1% | 59 | 9% ± 3% | 59 | 5% ± 1% | |
Hybrid | 59 | 4% ± 1% | 59 | 6% ± 1% | 59 | 4% ± 1% | |
tCr | SVS-LCM | 32 | 8% ±3% | 59 | 5% ± 1% | 59 | 6% ± 1% |
wbMRSI | 59 | 3% ± 1% | 59 | 4% ± 1% | 59 | 3% ± 1% | |
Hybrid | 59 | 3% ± 0% | 59 | 3% ± 1% | 59 | 3% ± 0% | |
mI | SVS-LCM | 25 | 14% ± 5% | 59 | 10% ± 3% | 59 | 10% ± 3% |
wbMRSI | 57 | 11% ± 4% | 59 | 10% ± 3% | 59 | 8% ± 2% | |
Hybrid | 58 | 8% ± 4% | 59 | 6% ± 1% | 59 | 5% ± 1% | |
Gln | SVS-LCM | 14 | 22% ± 4% | 57 | 18% ± 4% | 42 | 22% ± 5% |
wbMRSI | 29 | 22% ± 5% | 47 | 18% ± 6% | 58 | 15% ± 4% | |
Hybrid | 47 | 18% ± 5% | 43 | 18% ± 6% | 46 | 19% ± 6% | |
Glu | SVS-LCM | 23 | 18% ± 5% | 59 | 13% ± 4% | 53 | 16% ± 5% |
wbMRSI | 55 | 13% ± 5% | 59 | 7% ± 3% | 58 | 6% ± 2% | |
Hybrid | 50 | 15% ± 5 % | 59 | 10% ± 3% | 58 | 11% ± 4% |
SVS-LCM spectral data were scanned with SVS and analyzed with LCModel, wbMRSI data were scanned with EPSI and analyzed with MIDAS, Hybrid data were scanned with EPSI and analyzed with LCModel
N represents number of sampled subjects. The data with linewidth >14Hz, Cramer-Rao lower bound >20% for NAA, tCho, and tCr, and >30% for Gln, Glu and MI were not sampled
BG represents the ROI in basal ganglia, oGM the ROI in occipital grey matter, and pWM the ROI in parietal white matter